BridgeBio Pharma (BBIO) Plummets 5.15%, Market Cap Shrinks to $820 Million
By ATTN Desk · Editorial oversight: Sean Han
Shares of BridgeBio Pharma (BBIO), listed on Nasdaq, closed at $85.53 on July 10 (local time), down 5.15% from the previous day’s close. This decline cut its market capitalization by approximately $821,210,458.79, bringing it down to roughly $16.767 billion.
On that day, trading volume for BridgeBio Pharma shares totaled 5,288,198. No separate catalysts or public disclosures have been reported to explain the sharp price drop and market‐cap decrease.